Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

NCT07039318 is registered in ClinicalTrials.gov with National Institute of Blood and Marrow Transplant (NIBMT), Pakistan as lead sponsor.

NCT NCT07039318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial
Lead sponsor
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2022
Completion date
May 31, 2025
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease